Business Description
![Virpax Pharmaceuticals Inc Virpax Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C0000C22E.png?14)
Virpax Pharmaceuticals Inc
NAICS : 541714
SIC : 2833
ISIN : US9282511073
Share Class Description:
VRPX: Ordinary SharesDescription
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | -0.39 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -15.9 | |||||
3-Year EPS without NRI Growth Rate | -13.4 | |||||
3-Year FCF Growth Rate | -39.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | 53.83 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 66.48 | |||||
9-Day RSI | 44.33 | |||||
14-Day RSI | 35.19 | |||||
6-1 Month Momentum % | -78.13 | |||||
12-1 Month Momentum % | -93.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.72 | |||||
Quick Ratio | 0.72 | |||||
Cash Ratio | 0.43 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -37.5 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -243.14 | |||||
ROA % | -140.18 | |||||
ROIC % | -522.4 | |||||
ROCE % | -267.65 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | 0.02 | |||||
EV-to-EBITDA | 0.02 | |||||
EV-to-FCF | 0.02 | |||||
Earnings Yield (Greenblatt) % | 5000 | |||||
FCF Yield % | -982.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VRPX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Virpax Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -14.42 | ||
Beta | 1.28 | ||
Volatility % | 97.28 | ||
14-Day RSI | 35.19 | ||
14-Day ATR ($) | 0.098528 | ||
20-Day SMA ($) | 0.606618 | ||
12-1 Month Momentum % | -93.2 | ||
52-Week Range ($) | 0.4603 - 10.7 | ||
Shares Outstanding (Mil) | 2.74 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Virpax Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Virpax Pharmaceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Virpax Pharmaceuticals Inc Frequently Asked Questions
What is Virpax Pharmaceuticals Inc(VRPX)'s stock price today?
The current price of VRPX is $0.58. The 52 week high of VRPX is $10.70 and 52 week low is $0.46.
When is next earnings date of Virpax Pharmaceuticals Inc(VRPX)?
The next earnings date of Virpax Pharmaceuticals Inc(VRPX) is 2024-08-14 Est..
Does Virpax Pharmaceuticals Inc(VRPX) pay dividends? If so, how much?
Virpax Pharmaceuticals Inc(VRPX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |